Maryland Zofran Birth Injury Attorney
Discovering you are pregnant is one of the most thrilling, nerve-wracking times in your life. Every choice you make has a potential impact on your child, including what you eat and drink, your activities, and even your sleeping patterns. But when your child is harmed because of a drug your healthcare professional assured you were perfectly safe to take during pregnancy, it can be devastating. Not only are you riddled with guilt and what-ifs, but you may now be facing countless hospital visits, surgeries, and a lifetime of constant fear and worry. Your child now has a congenital birth defect that may affect their quality of life for months or years, if not follow them for the rest of their life, as well as pain and suffering that otherwise would never have occurred, had that drug not been prescribed. If you or someone you know has delivered a child who has congenital birth defects caused by Zofran or the generic form, Ondansetron, contact a highly knowledgeable Maryland Zofran birth injury lawyer as soon as possible to discuss your case.
Why Choose Malloy Law Offices, LLC
Our team of experienced Zofran birth injury attorneys in Maryland can give you the best legal advice and plan for moving forward. The personal injury attorneys at Malloy Law Offices, LLC is equipped to handle your case with care while also fighting to get you justice.
What is Zofran?
Also known by its generic name ondansetron, Zofran is a class of medication designed to treat nausea and vomiting in cancer patients receiving moderate to aggressive chemotherapy, cancer patients receiving certain forms of radiotherapy (radiation), and post-operative patients. Zofran is a type of anti-emetic or anti-nausea drug that is called a selective serotonin 5HT3 receptor antagonist. Zofran works by blocking the serotonin receptors in the gastrointestinal tract and the corresponding location in the brain that would trigger nausea and vomiting. It was created by British-based pharmaceutical company GlaxoSmithKline and available on the market in 1991.
Zofran Safety Testing
During the 1980s, GlaxoSmithKline conducted animal studies in which it was determined that there was evidence of toxicity, malformations, and intrauterine deaths in offspring. A subsequent study in humans confirmed the initial study’s findings that the active ingredient in Zofran, ondansetron, readily crossed the placenta barrier and exposed developing fetuses to high levels of the drug. This information, however, was buried by GlaxoSmithKline. Instead, GlaxoSmithKline labeled Zofran as a Pregnancy Category B drug, following the FDA’s at-the-time pregnancy categorization scheme. By extension, all generic forms of Zofran were labeled in this way, as well.
How a Maryland Zofran Birth Injury Lawyer Can Help
If you or someone you know took Zofran or the generic form, ondansetron, during the first trimester of pregnancy and subsequently delivered an infant with congenital birth defects, you may be entitled to compensation. Call (888) 607-8690 or contact us to speak with a highly skilled Zofran birth injury lawyer as soon as possible to discuss the facts of your case. An injury attorney will be able to review your records and determine whether or not Zofran, and by extension, GlaxoSmithKline, was the cause of your baby’s pain and suffering.